Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

ABCL-314 Durable Efficacy and Manageable Safety in Patients Aged ≥75 Years with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Treated with Tisagenlecleucel in the Real-World Setting

Daniel J. Landsburg,Michael Heim,Amy Moskop,Stephen Ronan Foley,Brian T. Hill, Grant Schofield,Caron A. Jacobson,Samantha Jaglowski,Frederick L. Locke,Ron Ram,Peter A. Riedell,Gunjan L. Shah,Leslie L. Popplewell,Ranjan Tiwari,Harald Maier,Marta Majdan,Marcelo C. Pasquini,Matthew J. Frigault

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited 0|Views0
Key words
ABCL,large B-cell lymphoma,relapsed/refractory,tisagenlecleucel,elderly,real-world evidence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined